Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LABCORP HOLDINGS INC. Director's Dealing 2023

Feb 14, 2023

30237_dirs_2023-02-14_d0e242e5-8eb7-4983-b902-a424f2f71941.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2023-02-11

Reporting Person: Summy Amy B. (EVP, Chief Marketing Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-02-11 Common Stock M 180 Acquired 757 Direct
2023-02-13 Common Stock F 54 $248.13 Disposed 703 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-02-11 Restricted Stock Unit $ M 180 Disposed Common Stock (180) Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: Stock withholding to satisfy tax withholding obligations.

F3: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2023.

F4: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.